| [1] |
Islami F, Ward EM, Sung H, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics[J]. J Natl Cancer Inst, 2021, 113(12): 1648-1669.
|
| [2] |
Liang ZH, He YQ, Hu X. Cardio-oncology: mechanisms, drug combinations, and reverse cardio-oncology[J]. Int J Mol Sci, 2022, 23(18): 10617.
|
| [3] |
Rivankar S. An overview of doxorubicin formulations in cancer therapy[J]. J Cancer Res Ther, 2014, 10(4): 853-858.
|
| [4] |
Quiles JL, Huertas JR, Battino M, et al. Antioxidant nutrients and adriamycin toxicity[J]. Toxicology, 2002, 180(1): 79-95.
|
| [5] |
Carvalho FS, Burgeiro A, Garcia R, et al. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy[J]. Med Res Rev, 2014, 34(1): 106-135.
|
| [6] |
Ma YG, Zhang XW, Bao HY, et al. Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice[J]. PLoS One, 2012, 7(7): e40763.
|
| [7] |
Wang SB, Song P, Zou MH. Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes[J]. J Biol Chem, 2012, 287(11): 8001-8012.
|
| [8] |
Werlein C, Ackermann M, Stark H, et al. Inflammation and vascular remodeling in COVID-19 hearts[J]. Angiogenesis, 2022: 1-16.
|
| [9] |
Shannon VR. Cancer Treatment-Related Lung Injury[M]// Oncologic Critical Care. Cham: Springer, 2020: 531-556.
|
| [10] |
Bowen TJ, Hall AR, Lloyd GR, et al. An extensive metabolomics workflow to discover cardiotoxin-induced molecular perturbations in microtissues[J]. Metabolites, 2021, 11(9): 644.
|
| [11] |
Zhang D, Lü JT, Ren ZX, et al. Potential cardiotoxicity induced by Euodiae Fructus: In vivo and in vitro experiments and untargeted metabolomics research[J]. Front Pharmacol, 2022, 13: 1028046.
|
| [12] |
Han ZD, Guo LL, Yu XY, et al. Network-driven targeted analysis reveals that Astragali Radix alleviates doxorubicin-induced cardiotoxicity by maintaining fatty acid homeostasis[J]. J Ethnopharmacol, 2022, 287: 114967.
|
| [13] |
Bleomycin Sulfate for Injection, USP [Drug Instruction]. Tokyo: Nippon Kayaku Co. , Ltd. , 2010. https://www. accessdata. fda. gov/drugsatfda_docs/label/2010/050443s036lbl. pdf.
|
| [14] |
Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human[J]. J Basic Clin Pharm, 2016, 7(2): 27-31.
|
| [15] |
Izbicki G, Segel MJ, Christensen TG, et al. Time course of bleomycin-induced lung fibrosis[J]. Int J Exp Pathol, 2002, 83(3): 111-119.
|
| [16] |
Doxorubicin Hydrochloride for Injection, USP [Drug Instruction]. New York: Pfizer Labs Division of Pfizer Inc, 2011. https://pfe-pfizercom-d8-prod. s3. amazonaws. com/products/uspi_doxorubicin_powder. pdf.
|
| [17] |
de Armas S, Huertas-Ayala C, Chan RY, et al. Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution[J]. Pediatr Blood Cancer, 2022, 69(5): e29601.
|
| [18] |
Lopaschuk GD, Karwi QG, Tian R, et al. Cardiac energy metabolism in heart failure[J]. Circ Res, 2021, 128(10): 1487-1513.
|
| [19] |
Li YY, Xiong ZY, Yan WJ, et al. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation[J]. Theranostics, 2020, 10(12): 5623-5640.
|
| [20] |
Murashige D, Jung JW, Neinast MD, et al. Extra-cardiac BCAA catabolism lowers blood pressure and protects from heart failure[J]. Cell Metab, 2022, 34(11): 1749-1764. e7.
|
百度学术
下载:
